Keyword: AstraZeneca

News

AstraZeneca Initiates Broad Genomics Project

28.04.2016 - As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...

News

AstraZeneca Seen as Contender for Medivation

19.04.2016 - As the drug world’s M&A carousel continues to turn, British-Swedish drugmaker Astra Zeneca is being eyed as the latest contender to enter the race to buy US biotech firm Medivation...

News

Lilly, AstraZeneca Alzheimer's Trial Advances

11.04.2016 - Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...

News

Pfizer and Allergan Bury Merger Plans

07.04.2016 - The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...

Strategy & Management

The Art of the Alliance

04.04.2016 - Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...

News

Sun Pharma Buys Novartis Drugs

04.04.2016 - Indian generic drug maker Sun Pharma has agreed to buy a portfolio of brands from Novartis for $293 million. The Mumbai-based multi-national is acquiring 14 established...

News

AstraZeneca Shareholders Target CEO Pay

16.03.2016 - AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...

News

AstraZeneca Sells Moventig Rights to ProStrakan

08.03.2016 - UK-Swedish drugs maker AstraZeneca has agreed to sell the European rights for Moventig to ProStrakan, a subsidiary of Japanese life sciences company Kyowa Hakko Kirin. The drug is...